GlassScriptPhysician profile
Smrita Sinha
NPI 1184872848
$645.43
in general payments reported to CMS, 2019-2025
13 companies · $369 in 2025
The $369 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $276 · 2025: $369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $645.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $645.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ardelyx, INC. | $225.30 | 2024-2025 | Ibsrela |
| Celltrion USA INC. | $84.90 | 2025 | Vegzelma |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $69.77 | 2024-2025 | Xifaxan |
| Abbvie INC. | $52.97 | 2025 | |
| Novo Nordisk INC | $41.08 | 2025 | Wegovy |
| Takeda Pharmaceuticals U.S.A., INC. | $34.88 | 2025 | Eohilia, Gattex |
| Ferring Pharmaceuticals INC. | $26.51 | 2025 | Rebyota |
| Micro-Tech Endoscopy USA, INC. | $26.15 | 2024 | Lesionhunter |
| Ironwood Pharmaceuticals, INC | $23.62 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.66 | 2024 | Cyltezo |
| Redhill Biopharma INC. | $16.59 | 2025 | Talicia |
| Axonics, INC. | $14.61 | 2024 | Axonics |
| Phathom Pharmaceuticals, INC. | $11.39 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Smrita Sinha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.